Oncology & Cancer

Benefit of novel drug in breast cancer seen in blood within weeks

Clinical benefit from use of a novel histone deacetylase inhibitor drug may be determined by examining blood cells days after a patient receives treatment. The drug, entinostat, is the first histone deacetylase inhibitor ...

page 9 from 24